Hydroxyoxazolidines as α-aminoacetaldehyde equivalents: Novel inhibitors of calpain

Bioorganic and Medicinal Chemistry Letters

Volumn 9, Issue 16, 1999, Pages 2365-2370

  Peet, Norton P ^a   Kim, Hwa Ok ^a   Marquart, Angela L ^a   Angelastro, Michael R ^a   Nieduzak, Thaddeus R ^a   White, Julie N ^a   Friedrich, Dirk ^a   Flynn, Gary A ^a   Webster, Mark E ^a   Vaz, Roy J ^a   Linnik, Matthew D ^a   Koehl, Jack R ^a   Mehdi, Shujaath ^a   Philippe, Bey ^a   Emary, Bart ^a   Hwang, Kin Kai ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

[1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER; [1 [5 HYDROXY 4 (PHENYLMETHYL) 3 OXAZOLIDINYL)CARBONYL] 2 ETHYLPROPYL]CARBAMIC ACID PHENYLMETHYL ESTER; CALPAIN; CALPASTATIN; OXAZOLIDINE DERIVATIVE; PRODRUG; UNCLASSIFIED DRUG; CARBAMIC ACID DERIVATIVE; MDL 104903; OXAZOLE DERIVATIVE; PROTEINASE INHIBITOR;

ARTICLE; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; NEUROPROTECTION; REACTION ANALYSIS; STEREOCHEMISTRY; CHEMISTRY; DRUG ANTAGONISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

CALPAIN; CARBAMATES; MAGNETIC RESONANCE SPECTROSCOPY; OXAZOLES; PROTEASE INHIBITORS;

EID: 0033575512     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(99)00391-1     Document Type: Article

References (36)

1. Wells, G. J.; Bihovsky, R. Exp. Opin. Ther. Patents 1998, 8, 1707.
2. Angelastro, M. R.; Mehdi, S.; Burkhart, J. P.; Peet, N. P.; Bey, P. J. Med. Chem. 1990, 33, 11.
3. (a) Johnson, M. P.; Markgraf, C. G.; Velayo, N. L.; McCarty, D. R.; Chmielewski, M. D.; Koehl, J. R.; Mehdi, S.; Angelastro, M. R.; Linnik, M. D. Stroke 1997, 28, 254;
4. (b) Rami, A.; Ferger, D.; Krieglstein, J. Neuroscience Res. 1997, 27, 93;
5. (c) Jordan, J.; Galindo, M. F.; Miller, R. J. J. Neurochem. 1997, 68, 1612;
6. (d) Linnik, M. D.; Markgraf, C. G.; Mason, P. J.; Velayo, N.; Racke, M. M. In Pharmacology of Cerebral Ischemia; Krieglstein, J., Ed.; Medpharm Scientific Publishers, Stattgart, 1996, p 33;
7. (e) Citron, M.; Diehl, T. S.; Gordon, G.; Biere, A.L.; Seubert, P.; Selkoe, D. J. Proc. Natl. Acad. Sci. U.S. 1996, 93, 13170;
8. (f) Bronson, J. R.; Marcuccilli, C. J.; Miller, R. J. Stroke 1995, 26, 1259;
9. (g) Hong, S-C.; Goto, Y.; Lanzino, G.; Soleau, S.; Kassell, N.; Lee, K.S. Stroke 1994, 25, 663;
10. (h) Squier, M. K. T.; Miller, A. C. K.; Malkinson, A. M.; Cohen, J. J. J. Cell. Phys. 1994, 159, 229;
11. (i) Song, D-K.; Malmstrom, T.; Kater, S. B.; Mykles, D. L. J. Neuroscience Res. 1994, 39, 474;
12. (j) Caner, H.; Collins, J. L.; Harris, S. M.; Kassell, N. F.; Lee, K. S. Brain Res. 1993, 607, 354;
13. (k) Hiramatsu, K.; Kassell, N. F.; Lee, K. S. Stroke 1993, 24, 1725;
14. (l) Rami, A.; Krieglstein, J. Brain Res. 1993, 609, 67;
15. (m) Minami, N.; Tani, E.; Maeda, Y.; Yamaura, I.; Fukami, M. J. Neurosurg. 1992, 76, 111;
16. (n) Arlinghaus, L.; Mehdi, S.; Lee, K. S. Eur. J. Pharmacol. 1991, 209, 123.
17. Kim, H-O.; Friedrich, D.; Huber, E. W.; Peet, N. P. Syn. Commun. 1996, 26, 3453.
18. 9 has been employed as the cyclizing agent.
19. Holcomb, R. C.; Schow, S.; Ayralkaloustian, S.; Powell, D. Tetrahedron Lett. 1994, 35, 7005.
20. Walter, M. W.; Adlington, R. M.; Baldwin, J. E.; Chuhan, J.; Schofield, C. J. Tetrahedron Lett. 1995, 36, 7761.
21. Karady, S.; Amato, J. S.; Weinstock, L. M. Tetrahedron Lett. 1984, 25, 4337.
22. Cheng, H. M.; Keitz, P.; Jones, J. B. J. Org. Chem. 1994, 59, 7671.
23. Knochel, P.; Brieden, W.; Rozema, M. J.; Eisenberg, C. Tetrahedron Lett. 1993, 37, 5881.
24. 5: C, 66.98; H, 6.83; N, 6.79. Found: C, 66.88; H, 7.07; N, 6.81.
25. 6: C, 66.07; H, 6.65; N, 6.16. Found: C, 65.76; H, 6.60; N, 6.16.
26. Jouin, P.; Castro, B. J. Chem. Soc., Perkin Trans. 1 1987, 1177.
27. Hendrickson, J. B.; Blair, K. W.; Keehn, P. M. Tetrahedron Lett. 1976, 603.
28. 2).
29. Lipton, M.F.; Basha, A.; Weinreb, S. M. Org. Syn., Coll. Vol. VI, 492, John Wiley & Sons, Inc., New York, NY, 1988.
30. Jia, Z.; Hasnain, S.; Hirama, T.; Lee, X.; Mort, J. S.; To, R.; Huber, C. P. J. Biol. Chem. 1995, 270, 5527.
31. (a) Dreyfuss, P. J. Med. Chem. 1974, 17, 252;
32. (b) Bodanszky, M.; Martinez, J.; Priestley, G. P.; Gardner, J. D.; Mutt, V. J. Med. Chem. 1978, 21, 1030.
33. Mancuso, A. G.; Huang, S.-L.; Swern, D. J. Org. Chem. 1978, 43, 2480.
34. 13C NMR. The minor isomer was consistent with inverse stereochemistry for both the benzyl and hydroxyl groups. Resonance assignments for these two components were derived from a DFQ-COSY spectrum, and relative stereochemistry was assigned from observation of NOE signals in a NOESY spectrum.
35. Angelastro, M. R.; Marquart, A. L.; Mehdi, S.; Koehl, J. R.; Vaz, R. J.; Bey, P.; Peet, N. P. Biorg. Med. Chem. Lett. 1999, 9, 139.
36. i values were determined as described in the following reference: Mehdi, S.; Angelastro, M. R.; Wiseman, J. S.; Bey, P. Biochem. Biophys. Res. Comm. 1988, 157, 1117.